TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Daniel D Von Hoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.